Postmenopausal Clinical Trial
Official title:
A Single-center, Randomized, Controlled, Open-labelled, Two-armed, Interventional Clinical Trial Investigating the Effect of a 12 Week Iyengar Yoga Intervention on the Bio-functional Age of Postmenopausal Women.
The purpose of this Study is to find out if Iyengar-Yoga has a rejuvenating effect on women after menopause. The biofunctional status of the study participants will be assessed before and after a 12-week yoga program.
Postmenopausal women qualifying as participants for the study are patients at the Universitätsklinik für Frauenheilkunde in Bern or are recruited through public advertisement. After giving informed consent the patients will be screened for inclusion and exclusion criteria and their biofunctional Status will be assessed. The participants of the study will then be randomly assigned to the intervention group (12 week yoga program) or to the control group. In addition to the 90 minutes yoga sessions instructed by a professional yoga teacher, the participants of the intervention group are asked to perform two yoga sessions lasting 45 minutes per week at home and document these in a diary. After the 12 weeks the biofunctional Status of all participants of the study will be reassessed. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02235051 -
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
|
N/A | |
Completed |
NCT01635413 -
Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)
|
N/A | |
Completed |
NCT00701337 -
Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route
|
Phase 4 | |
Withdrawn |
NCT03238703 -
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
|
Phase 4 | |
Completed |
NCT03756272 -
Stellate Ganglion Block to Reduce Hot Flushes
|
N/A | |
Recruiting |
NCT03953157 -
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
|
N/A | |
Completed |
NCT00338728 -
Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT01482702 -
Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors
|
N/A | |
Not yet recruiting |
NCT05009238 -
Effect of l S Exercises on Balance and Spatiotemporal Gait Parameters in P M Women
|
N/A | |
Terminated |
NCT01842217 -
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
|
N/A | |
Completed |
NCT01172574 -
Motor Control Exercise in Osteoporotic Women
|
N/A | |
Completed |
NCT00530582 -
Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women
|
Phase 4 | |
Completed |
NCT01825785 -
A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)
|
Phase 1 | |
Completed |
NCT04364061 -
Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE)
|
N/A | |
Completed |
NCT03180294 -
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
|
Phase 2 | |
Recruiting |
NCT06445842 -
Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
|
N/A | |
Completed |
NCT01753908 -
Broccoli Sprout Extract in Treating Patients With Breast Cancer
|
Early Phase 1 | |
Not yet recruiting |
NCT06377631 -
Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity
|
N/A | |
Recruiting |
NCT06228768 -
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer
|
N/A | |
Terminated |
NCT01294397 -
Effects of Denosumab on the Pharmacokinetics of Etanercept
|
Phase 1 |